This HTML5 document contains 63 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023728%3A_____%2F05%3A00000230%21RIV10-MZ0-00023728/
n9http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n13http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n8http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023728%3A_____%2F05%3A00000230%21RIV10-MZ0-00023728
rdf:type
skos:Concept n13:Vysledek
dcterms:description
Two hundred nine patients with active rheumatoid arthritis, who were receiving methotrexate for at least 6 months, were randomized in a double-blind fashion to receive: placebo and three doses of interferon-? administered in subcutaneous injections for the duration of 24 weeks. At the doses tested, treatment with IFN-3 times weekly did not induce a clinical or radiological effect in RA patients Two hundred nine patients with active rheumatoid arthritis, who were receiving methotrexate for at least 6 months, were randomized in a double-blind fashion to receive: placebo and three doses of interferon-? administered in subcutaneous injections for the duration of 24 weeks. At the doses tested, treatment with IFN-3 times weekly did not induce a clinical or radiological effect in RA patients
dcterms:title
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
skos:prefLabel
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
skos:notation
RIV/00023728:_____/05:00000230!RIV10-MZ0-00023728
n3:aktivita
n7:V
n3:aktivity
V
n3:cisloPeriodika
1
n3:dodaniDat
n8:2010
n3:domaciTvurceVysledku
n9:8827559 n9:1266853
n3:druhVysledku
n15:J
n3:duvernostUdaju
n10:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
510918
n3:idVysledku
RIV/00023728:_____/05:00000230
n3:jazykVysledku
n16:eng
n3:klicovaSlova
multicentre; randomised; double; blind; placebo; controlled; phase; study; subcutaneous; interferon; beta-1a; treatment; patients; active; rheumatoid; arthritis
n3:klicoveSlovo
n4:study n4:phase n4:active n4:randomised n4:subcutaneous n4:interferon n4:blind n4:patients n4:controlled n4:arthritis n4:double n4:beta-1a n4:placebo n4:rheumatoid n4:treatment n4:multicentre
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[87A9FA680F13]
n3:nazevZdroje
Annals of Rheumatic Diseases
n3:obor
n14:FE
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
14
n3:rokUplatneniVysledku
n8:2005
n3:svazekPeriodika
64
n3:tvurceVysledku
Furst, D. Van Holten, J. Herrero-Beaumont, G. Alvaro, J. Genovese, M. Tak, P. P. Rozman, B. McInnes, I. B. Musikic, P. Nuki, G. Kivitz, A. J. Pavelka, Karel Vencovský, Jiří Stahl, H.
n3:wos
000225800100014
s:issn
0003-4967
s:numberOfPages
6